Skip to content
Screener

Alkermes ALKS Equity Method Investments

Equity Method Investments at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$4.3M0.0%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$27M0.0%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$229.56M+122%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$123.03M+619%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$55.1M-49.0%

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.29B+88.0%
Enterprise value$9.35B+136%
P/E125.3×+113×
P/S+2.0×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
Prepaid expenses and other current assets110,89579,090
Total current assets1,522,9061,929,161
PROPERTY, PLANT AND EQUIPMENT, NET218,284221,722
INVESTMENTS—LONG-TERM35,054145
RIGHT-OF-USE ASSETS76,11177,209
INTANGIBLE ASSETS, NET1,761,456815
GOODWILL594,27383,027
DEFERRED TAX ASSETS123,041125,815

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's equity method investments?
Alkermes (ALKS) reported equity method investments of $35.05M in Q2 2026.
How has Alkermes's equity method investments changed year-over-year?
Alkermes's equity method investments decreased by 8.4% year-over-year, from $38.27M to $35.05M.
What is the long-term trend for Alkermes's equity method investments?
Over 5 years (2020 to 2025), Alkermes's equity method investments has grown at a -64.2% compound annual growth rate (CAGR), from $24.78M to $145K.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.

Ask your AI about Alkermes's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude